Correction: Application of next-generation imaging in biochemically recurrent prostate cancer.
Publication
, Journal Article
Moul, JW; Shore, ND; Pienta, KJ; Czernin, J; King, MT; Freedland, SJ
Published in: Prostate Cancer Prostatic Dis
June 2024
Duke Scholars
Published In
Prostate Cancer Prostatic Dis
DOI
EISSN
1476-5608
Publication Date
June 2024
Volume
27
Issue
2
Start / End Page
358
Location
England
Related Subject Headings
- Urology & Nephrology
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Moul, J. W., Shore, N. D., Pienta, K. J., Czernin, J., King, M. T., & Freedland, S. J. (2024). Correction: Application of next-generation imaging in biochemically recurrent prostate cancer. Prostate Cancer Prostatic Dis, 27(2), 358. https://doi.org/10.1038/s41391-024-00791-6
Moul, Judd W., Neal D. Shore, Kenneth J. Pienta, Johannes Czernin, Martin T. King, and Stephen J. Freedland. “Correction: Application of next-generation imaging in biochemically recurrent prostate cancer.” Prostate Cancer Prostatic Dis 27, no. 2 (June 2024): 358. https://doi.org/10.1038/s41391-024-00791-6.
Moul JW, Shore ND, Pienta KJ, Czernin J, King MT, Freedland SJ. Correction: Application of next-generation imaging in biochemically recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2024 Jun;27(2):358.
Moul, Judd W., et al. “Correction: Application of next-generation imaging in biochemically recurrent prostate cancer.” Prostate Cancer Prostatic Dis, vol. 27, no. 2, June 2024, p. 358. Pubmed, doi:10.1038/s41391-024-00791-6.
Moul JW, Shore ND, Pienta KJ, Czernin J, King MT, Freedland SJ. Correction: Application of next-generation imaging in biochemically recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2024 Jun;27(2):358.
Published In
Prostate Cancer Prostatic Dis
DOI
EISSN
1476-5608
Publication Date
June 2024
Volume
27
Issue
2
Start / End Page
358
Location
England
Related Subject Headings
- Urology & Nephrology
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis